Biotechnology — Biobanking of parasites — Part 1: Helminths
Introduction: The biological industry has been using helminths to treat diseases such as Crohn’s disease, ulcerative colitis, auto-immune disease like allergic asthma, and even incurable disease like cancer. The industry is also developing anthelmintic drugs and rapid infection diagnosis methods. A biobank that can fulfil the role as a platform for collecting, storing and distributing parasitic resources is of urgent need. This document supports processes that maintain animal welfare, as it is anchored in the principle of the three Rs: to “Replace, Reduce and Refine the use of animals”[20]. This document deals with the management and operation of the biobank: Helminth, which can safely manage and supply uncontaminated parasitic resources for the biological industry to develop treatment of autoimmune diseases, parasite infection diagnostic tests, and anthelmintics. In this document, the following verbal forms are used: — “shall” indicates a requirement; — “should” indicates a recommendation; — “may” indicates a permission; — “can” indicates a possibility or a capability. © ISO 2024 – All rights reserved
Scope: This document provides requirements for the biobanking of helminths as parasitic resources including the collection, safeguarding, classification, proliferation, preservation, storage and distribution of helminths. This document sets requirements for the quality of helminths and their associated data, the data collection, and safety management when handling the helminths as a source of human disease infection. This document is applicable to all organizations performing biobanking with helminths used for research and development. NOTE International, national or regional regulations or requirements, or multiple of them, can also apply to specific topics covered in this document.